| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.18 | 0.0009 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.002 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.002 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.089 | 0.006 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.09 | 0.008 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.009 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.079 | 0.01 |